KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMY) Net Income towards Common Stockholders (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Net Income towards Common Stockholders for 17 consecutive years, with $1.1 billion as the latest value for Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders rose 1328.95% to $1.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $7.1 billion, a 178.01% increase, with the full-year FY2025 number at $7.1 billion, up 178.99% from a year prior.
  • Net Income towards Common Stockholders was $1.1 billion for Q4 2025 at Bristol Myers Squibb, down from $2.2 billion in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $2.5 billion in Q1 2025 to a low of -$11.9 billion in Q1 2024.
  • A 5-year average of $957.5 million and a median of $1.6 billion in 2022 define the central range for Net Income towards Common Stockholders.
  • Peak YoY movement for Net Income towards Common Stockholders: plummeted 625.28% in 2024, then soared 1328.95% in 2025.
  • Bristol Myers Squibb's Net Income towards Common Stockholders stood at $2.4 billion in 2021, then decreased by 14.63% to $2.0 billion in 2022, then dropped by 15.7% to $1.7 billion in 2023, then crashed by 95.55% to $76.0 million in 2024, then skyrocketed by 1328.95% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Net Income towards Common Stockholders are $1.1 billion (Q4 2025), $2.2 billion (Q3 2025), and $1.3 billion (Q2 2025).